DE3511236A1 - Praeparat mit synergistischer bronchienerweiternder wirkung und verfahren zu dessen herstellung - Google Patents

Praeparat mit synergistischer bronchienerweiternder wirkung und verfahren zu dessen herstellung

Info

Publication number
DE3511236A1
DE3511236A1 DE19853511236 DE3511236A DE3511236A1 DE 3511236 A1 DE3511236 A1 DE 3511236A1 DE 19853511236 DE19853511236 DE 19853511236 DE 3511236 A DE3511236 A DE 3511236A DE 3511236 A1 DE3511236 A1 DE 3511236A1
Authority
DE
Germany
Prior art keywords
theophylline
terbutaline
preparation
synergistic
microencapsulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19853511236
Other languages
German (de)
English (en)
Other versions
DE3511236C2 (US07847105-20101207-C00016.png
Inventor
Andreas 2000 Wedel Feulner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of DE3511236A1 publication Critical patent/DE3511236A1/de
Application granted granted Critical
Publication of DE3511236C2 publication Critical patent/DE3511236C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE19853511236 1984-04-04 1985-03-28 Praeparat mit synergistischer bronchienerweiternder wirkung und verfahren zu dessen herstellung Granted DE3511236A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8401856A SE8401856D0 (sv) 1984-04-04 1984-04-04 New pharmaceutical preparations

Publications (2)

Publication Number Publication Date
DE3511236A1 true DE3511236A1 (de) 1985-10-17
DE3511236C2 DE3511236C2 (US07847105-20101207-C00016.png) 1991-05-02

Family

ID=20355438

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853511236 Granted DE3511236A1 (de) 1984-04-04 1985-03-28 Praeparat mit synergistischer bronchienerweiternder wirkung und verfahren zu dessen herstellung

Country Status (2)

Country Link
DE (1) DE3511236A1 (US07847105-20101207-C00016.png)
SE (1) SE8401856D0 (US07847105-20101207-C00016.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795643A (en) * 1987-02-02 1989-01-03 Mepha Ag Dornacherstrasse 114 Medicament with a delayed release of active ingredient
WO2004050067A1 (en) * 2002-11-29 2004-06-17 Cipla Limited PHARMACEUTICAL FORMULATIONS COMPRISING β-2 ADRENORECEPTOR AGONISTS AND XANTHINES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2390164A1 (fr) * 1977-05-13 1978-12-08 Blanie Paul Association a action anti-asthmatique

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Eur. J. Resp. Dis. 63, S. 13-22, 1982 *
Eur. J. Resp. Dis. Suppl. 61, S. 83-91, 1980 *
Pediatrics 64, Nr. 4, S. 508-513, 1981 *
Rote Liste 1984, Nr. 27044, 27046, 27049 bis 27051, 27063, 27069 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795643A (en) * 1987-02-02 1989-01-03 Mepha Ag Dornacherstrasse 114 Medicament with a delayed release of active ingredient
WO2004050067A1 (en) * 2002-11-29 2004-06-17 Cipla Limited PHARMACEUTICAL FORMULATIONS COMPRISING β-2 ADRENORECEPTOR AGONISTS AND XANTHINES
GB2410187A (en) * 2002-11-29 2005-07-27 Cipla Ltd Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines
GB2410187B (en) * 2002-11-29 2007-06-20 Cipla Ltd Pharmaceutical formulations comprising ß-2 adrenoreceptor agonists and xanthines

Also Published As

Publication number Publication date
SE8401856D0 (sv) 1984-04-04
DE3511236C2 (US07847105-20101207-C00016.png) 1991-05-02

Similar Documents

Publication Publication Date Title
DE69323428T2 (de) Morphinzubereitungen mit kontrollierter freisetzung
DE602004010531T2 (de) Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
DE68905096T2 (de) Niacin und guar-mehl enthaltende zusammensetzung.
DE19541128C2 (de) Stabilisierte schilddrüsenhormonhaltige Arzneimittel
DE69117922T2 (de) Zusammensetzungen gegen malaria
DE3855323T2 (de) Galenische 2-beta-Mimetik-Formen für die per- und sublinguale Verabreichung
DE3390114C2 (US07847105-20101207-C00016.png)
EP1165081B1 (de) Verfahren zum herstellen tolperison-enthaltender pharmazeutischer zubereitungen zur oralen verabreichung
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
EP0250648A2 (de) Pharmazeutisches Präparat zur verzögerten Freigabe von Ibuprofen
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE69100954T2 (de) Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung.
DE69103624T2 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
DE2854316C2 (US07847105-20101207-C00016.png)
DE2166355C2 (de) Verwendung von d,1-Sobrerol bei der Balsamtherapie der Atemwege
DE69630073T2 (de) (-)Hydroxycitrat enthaltende Verbindungen mit neuen therapeutischen Wirkungen
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE3609005A1 (de) Pharmazeutische zusammensetzungen mit metabolischer aktivitaet
EP0207193A2 (de) Synergistische Kombination von Flupirtin und 4-Acetamido-phenol
DE3511236C2 (US07847105-20101207-C00016.png)
WO1998058639A1 (de) Synergistisch wirkende zusammensetzungen zur selektiven bekämpfung von tumorgewebe
EP0471388A2 (de) Mittel zur Behandlung der Herzinsuffizienz
DE3315607A1 (de) Verwendung von albendazol in oraler verabreichungsform bei der bekaempfung von echinokokkose des menschen und arzneimittel
DE69426317T2 (de) Verwendung von Beta-Naphthochinonderivaten zur Hemmung von Blutplättchen-Aggregation
DE2456172C3 (de) Arzneimittel bei rheumatischen Erkrankungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition